INFLUENCE OF VERTEPORFIN PHOTODYNAMIC THERAPY ON INFLAMMATION IN HUMAN CHOROIDAL NEOVASCULAR MEMBRANES SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Authors:
- Annemarie AdamAAAnnemarie Adam
- Kei ShinodaKSKei Shinoda
- Efdal YoeruekEYEfdal Yoeruek
- Peter SzurmanPSPeter Szurman
- Silvia BoppSBSilvia Bopp
- Claus EckardtCEClaus Eckardt
- Karl Ulrich Bartz-SchmidtKBKarl Ulrich Bartz-Schmidt
- Salvatore GrisantiSGSalvatore Grisanti
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (6) , 713-723
Abstract
To examine the short- and long-term consequences of verteporfin photodynamic therapy (PDT) on inflammation with regard to infiltration of macrophages and leukocytes and expression of thy-1 in human choroidal neovascularization membranes (CNV) secondary to age-related macular degeneration (AMD). Retrospective review of an interventional case series of 43 patients who underwent removal of CNV. Twenty patients were treated with PDT 3 to 246 days preoperatively. Twenty-three CNV without previous treatment were used as control. CNV were stained for CD34, CD105, cytokeratin 18, Ki-67, thy-1, an endothelial cell glycoprotein known to be upregulated only by inflammatory cytokines, CD68 (macrophages), and CD45 (common leukocyte antigen). Specimens treated by PDT 3 days previously showed significantly reduced endothelial thy-1 expression (P = 0.008), leukocyte (P=0.04) and macrophage (P=0.0063) infiltration, and proliferative activity (P=0.02) compared to control CNV. Specimens at longer intervals after PDT, in contrast, disclosed a significantly increased expression of thy-1 (P=0.004), infiltration with leukocytes (P=0.044) and macrophages (P=0.01), and proliferative activity (P=0.03) compared to CNV excised 3 days after PDT. The rebound effect after PDT seems to be based on an inflammatory response that contributes to enhanced proliferation. These data support the need for an anti-inflammatory therapy as adjuvant to PDT.Keywords
This publication has 58 references indexed in Scilit:
- Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranesBritish Journal of Ophthalmology, 2006
- Verteporfin and Intravitreal Triamcinolone Acetonide Combination Therapy for Occult Choroidal Neovascularization in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2006
- The Effect of Autologous Serum Eye Drops in the Treatment of Severe Dry Eye Disease: A Prospective Randomized Case-Control StudyAmerican Journal of Ophthalmology, 2005
- Makula-Translokation nach photodynamischer Therapie: ein FallberichtKlinische Monatsblätter für Augenheilkunde, 2005
- Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findingsSST report no. 11Ophthalmology, 2004
- Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapyOncogene, 2004
- The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisationBritish Journal of Ophthalmology, 2004
- Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic CellsClinical Cancer Research, 2004
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Activated Macrophages in Experimental Subretinal Neovascularization (With 1 color plate)Ophthalmologica, 1990